Jason B. Daly
EVP, Chief Legal Officer · 3 filings · Latest: Aug 11, 2026
Amneal Pharmaceuticals, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
AMRX | Jason B. Daly | EVP, Chief Legal Officer | Aug 12, 2026 | Sale | $17.40 | 210,000 | $3.7M | 35,171 | |
AMRX | Jason B. Daly | EVP, Chief Legal Officer | Aug 11, 2026 | Sale | $17.70 | 6,613 | $117.1K | 245,171 | |
AMRX | JASON DALY | — | Aug 11, 2026 | Proposed Sale | $17.36 | 210,000 | $3.6M | — | |
AMRX | Jason B. Daly | EVP, Chief Legal Officer | Mar 4, 2026 | Option Exercise | — | 35,880 | — | 267,364 | |
AMRX | Jason B. Daly | EVP, Chief Legal Officer | Mar 3, 2026 | Option Exercise | — | 390,939 | — | 364,267 | |
AMRX | Daly Jason B. | — | Aug 12, 2025 | Proposed Sale | $9.00 | 22,000 | $198.0K | — | |
AMRX | Daly Jason B. | — | Mar 5, 2025 | Proposed Sale | $8.80 | 90,000 | $792.0K | — | |
AMRX | Daly Jason B. | — | Nov 15, 2024 | Proposed Sale | $8.50 | 57,322 | $487.2K | — |